Growth Metrics

Medicale (MCLE) Cash from Financing Activities (2020 - 2025)

Medicale (MCLE) has disclosed Cash from Financing Activities for 6 consecutive years, with $6457.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 58.37% year-over-year to $6457.0, compared with a TTM value of $22849.0 through Sep 2025, down 72.66%, and an annual FY2025 reading of $22849.0, down 72.66% over the prior year.
  • Cash from Financing Activities was $6457.0 for Q3 2025 at Medicale, up from $2021.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $31082.0 in Q1 2024 and bottomed at $188.0 in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $10424.3, with a median of $7348.5 recorded in 2023.
  • The sharpest move saw Cash from Financing Activities soared 1277.66% in 2022, then crashed 85.94% in 2025.
  • Year by year, Cash from Financing Activities stood at $650.0 in 2021, then soared by 733.54% to $5418.0 in 2022, then skyrocketed by 411.37% to $27706.0 in 2023, then crashed by 63.91% to $10000.0 in 2024, then plummeted by 35.43% to $6457.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for MCLE at $6457.0 in Q3 2025, $2021.0 in Q2 2025, and $4371.0 in Q1 2025.